Aberrant function of the Ras signal transduction pathway in human breast cancer
- 1 January 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 35 (1), 133-144
- https://doi.org/10.1007/bf00694753
Abstract
Althoughras mutations are infrequent (approximately 5%) in breast cancers, there is considerable evidence that suggests that the pathways which Ras services may still be deregulated in breast cancer cells. The recent identification of many of the components of the Ras signal transduction pathway has defined a network of proto-oncogene proteins controlling diverse signaling events that regulate cell growth and differentiation. Consequently, mutations that perturb the function of any one component of this signal pathway may trigger the same oncogenic events as mutation ofras itself. Moreover, several Ras-related proteins have recently been demonstrated to possess the ability to trigger malignant transformation via signaling pathways shared with Ras proteins. Thus, it is possible that the aberrant function of Ras-related proteins may contribute to breast cancer development. Consequently, it is important not to dismiss the Ras pathway in the development of breast cancer merely because of the infrequent detection of mutations inras itself, but rather to consider the influence of aberrations upstream or downstream of Ras and of certain Ras-related proteins in the development of breast cancer. Finally, the critical importance of components upstream and downstream of Ras provides additional targets for rational drug design approaches to block the aberrant function of Ras signaling in human tumors.Keywords
This publication has 107 references indexed in Scilit:
- Anti-Ras drugs come of ageCurrent Biology, 1993
- Nonsense mutations in the C–terminal SH2 region of the GTPase activating protein (GAP) gene in human tumoursNature Genetics, 1993
- SH2 domains recognize specific phosphopeptide sequencesCell, 1993
- Triggering signaling cascades by receptor tyrosine kinasesTrends in Biochemical Sciences, 1992
- Small GTP-binding proteins and their role in transportCurrent Opinion in Cell Biology, 1991
- The GTPase superfamily: conserved structure and molecular mechanismNature, 1991
- Immunocytochemical and biochemical analysis of epidermal growth factor receptor expression in human breast cancer tissues: Relationship to estrogen receptor and lymphatic invasionInternational Journal of Cancer, 1989
- Independent Molecular Pathways in Initiation and Loss of Hormone Responsiveness of Breast CarcinomasScience, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987